Statements (8)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:developedBy |
Omeros Corporation
|
| gptkbp:intendedUse |
treatment of complement-mediated diseases
|
| gptkbp:mechanismOfAction |
MASP-3 inhibitor
|
| gptkbp:status |
preclinical development
|
| gptkbp:bfsParent |
gptkb:Orion_Nebula_complex
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
OMC-26
|